ProQR (PRQR - Research Report) received a Hold rating and price target from JMP Securities analyst Jonathan Wolleben today. The company's shares closed yesterday at $0.84.Wolleben covers the Healthcare sector, focusing on stocks such as Altimmune, Intercept Pharma, and Clearside Biomedical. According to TipRanks, Wolleben has an average return of -1.3% and a 44.63% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for ProQR with a $2.50 average price target.See the top stocks recommended by analysts >>The company has a one-year high of $9.09 and a one-year low of $0.53. Currently, ProQR has an average volume of 436.5K.
https://www.tipranks.com/news/blurbs/proqr-prqr-was-downgraded-to-a-hold-rating-at-jmp-securities?utm_source=advfn.com&utm_medium=referral
ProQR Therapeutics NV (NASDAQ:PRQR)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more ProQR Therapeutics NV Charts.
ProQR Therapeutics NV (NASDAQ:PRQR)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more ProQR Therapeutics NV Charts.